Tomoki Tamura

11PUBLICATIONS
19CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 11, 2025
A Case Report on the Development of Ulcerative Colitis During Osimertinib Therapy for Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer.

Tomoki Tamura, Misaki Tani, Hiromichi Ogata

|Dec 17, 2024
Frequency and Significance of Body Weight Loss During Immunochemotherapy in Patients with Advanced Non-Small Cell Lung Cancer.

Masataka Taoka, Eiki Ichihara, Toshihide Yokoyama

|Nov 27, 2024
The Clinical Significance of Interstitial Pneumonia with Autoimmune Features in Cryptogenic Organizing Pneumonia: A Prospective Multicenter Observational Study.

Hisao Higo, Hirohisa Ichikawa, Yukako Arakawa

|Oct 15, 2024
Ramucirumab-induced ascites with endothelial growth factor receptor mutation-positive non-small cell lung cancer: Two case reports.

Keisuke Shiraha, Tomoki Tamura, Taisaku Koyanagi

|Feb 08, 2024
Pneumocystis jirovecii pneumonia mortality risk associated with preceding long-term steroid use for the underlying disease: A multicenter, retrospective cohort study.

Kohei Miyake, Satoru Senoo, Ritsuya Shiiba

|Dec 23, 2022
The Effect of Pleural Effusion on Prognosis in Patients with Non-Small Cell Lung Cancer Undergoing Immunochemotherapy: A Retrospective Observational Study.

Tomoka Nishimura, Eiki Ichihara, Toshihide Yokoyama

Pageof 2

Frequent Collaborators

2 joint publications

Eiki Ichihara

2 joint publications

Hirohisa Kano

2 joint publications

Haruyuki Kawai

2 joint publications

Chihiro Ando